Mirabegron: pharmacoeconomic aspects of the use of the drug for the treatment of overactive bladder syndrome - O. I. Ivakhnenko; E. V. Derkach; V. S. Krysanova; A. D. Ermolaeva; K. A. Kokushkin (Качественная клиническая практика, 2022)